| Adventhealth Home Care Waterman | |
| 3260 Waterman Way, Tavares, Florida 32778 | |
| (352) 253-3900 | |
| Name | Adventhealth Home Care Waterman |
|---|---|
| Location | 3260 Waterman Way, Tavares, Florida |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 107155 |
| Ownership Type | Voluntary Non Profit - Religious Affiliation |
| Service Area Zip Codes | 32102, 32159, 32162, 32163, 32179, 32195, 32702, 32720, 32726, 32735, 32736, 32756, 32757, 32767, 32776, 32778, 32784, 33513, 33538, 33597, 34491, 34705, 34711, 34714, 34715, 34731, 34736, 34737, 34748, 34753, 34762, 34785, 34788, 34797 |
| NPI Number | 1023045853 |
| Organization Name | FLORIDA HOSPITAL WATERMAN INC |
| Doing Business As | HOME CARE SERVICES |
| Address | 9909 Us Hwy 441, Unit 2 Suite A, Leesburg, FL 34788 |
| Phone Number | 352-253-3900 |
News Archive
Ban cigarette filters. Start a deposit-return scheme for used butts. Hold manufacturers responsible for clean-ups. Place warnings on packets about the impact of simply flicking one's used cigarettes away.
The U.S. Food and Drug Administration has ordered Sun Valley Juice Company of Ketchum, Idaho, to stop receiving, processing, preparing, packing, holding, and distributing juice until the agency determines that the company is in compliance with laws and regulations applicable to producing food that is safe.
Researchers at the University of Calgary's Hotchkiss Brain Institute and Southern Alberta Cancer Research Institute have made a discovery that could prolong the life of people living with glioblastoma – the most aggressive type of brain cancer. Samuel Weiss, PhD, Professor and Director of the HBI, and Research Assistant Professor Artee Luchman, PhD, and colleagues, published their work today in Clinical Cancer Research, which is leading researchers to start a human phase I/II clinical trial as early as Spring 2015.
Shire plc, the global specialty biopharmaceutical company, today announced that it has received approval from the US Food and Drug Administration (FDA) for INTUNIV(TM) (guanfacine) Extended Release Tablets for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17 years.
Sudden infant death syndrome (SIDS) has been a cause for concern for a while now. The New Zealand Cot Study and European data in the 1990's had found that sleeping in prone position was dangerous for infants.
› Verified 2 days ago
| NPI Number | 1831131200 |
| Organization Name | FLORIDA HOSPITAL WATERMAN INC |
| Doing Business As | FLORIDA HOSPITAL WATERMAN HOME CARE SERVICES PRIVATE DIVISION |
| Address | 9909 Us Hwy 441, Unit 2 Suite B, Leesburg, FL 34788 |
| Phone Number | 352-253-3900 |
News Archive
Ban cigarette filters. Start a deposit-return scheme for used butts. Hold manufacturers responsible for clean-ups. Place warnings on packets about the impact of simply flicking one's used cigarettes away.
The U.S. Food and Drug Administration has ordered Sun Valley Juice Company of Ketchum, Idaho, to stop receiving, processing, preparing, packing, holding, and distributing juice until the agency determines that the company is in compliance with laws and regulations applicable to producing food that is safe.
Researchers at the University of Calgary's Hotchkiss Brain Institute and Southern Alberta Cancer Research Institute have made a discovery that could prolong the life of people living with glioblastoma – the most aggressive type of brain cancer. Samuel Weiss, PhD, Professor and Director of the HBI, and Research Assistant Professor Artee Luchman, PhD, and colleagues, published their work today in Clinical Cancer Research, which is leading researchers to start a human phase I/II clinical trial as early as Spring 2015.
Shire plc, the global specialty biopharmaceutical company, today announced that it has received approval from the US Food and Drug Administration (FDA) for INTUNIV(TM) (guanfacine) Extended Release Tablets for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17 years.
Sudden infant death syndrome (SIDS) has been a cause for concern for a while now. The New Zealand Cot Study and European data in the 1990's had found that sleeping in prone position was dangerous for infants.
› Verified 2 days ago
| Quality Rating: |
News Archive
Ban cigarette filters. Start a deposit-return scheme for used butts. Hold manufacturers responsible for clean-ups. Place warnings on packets about the impact of simply flicking one's used cigarettes away.
The U.S. Food and Drug Administration has ordered Sun Valley Juice Company of Ketchum, Idaho, to stop receiving, processing, preparing, packing, holding, and distributing juice until the agency determines that the company is in compliance with laws and regulations applicable to producing food that is safe.
Researchers at the University of Calgary's Hotchkiss Brain Institute and Southern Alberta Cancer Research Institute have made a discovery that could prolong the life of people living with glioblastoma – the most aggressive type of brain cancer. Samuel Weiss, PhD, Professor and Director of the HBI, and Research Assistant Professor Artee Luchman, PhD, and colleagues, published their work today in Clinical Cancer Research, which is leading researchers to start a human phase I/II clinical trial as early as Spring 2015.
Shire plc, the global specialty biopharmaceutical company, today announced that it has received approval from the US Food and Drug Administration (FDA) for INTUNIV(TM) (guanfacine) Extended Release Tablets for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17 years.
Sudden infant death syndrome (SIDS) has been a cause for concern for a while now. The New Zealand Cot Study and European data in the 1990's had found that sleeping in prone position was dangerous for infants.
› Verified 2 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 99.4 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99.7 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.7 | 99.6 |
| How often the home health team checked patients for depression | 99.3 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 65.3 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 72.7 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 98.1 | 96.4 |
News Archive
Ban cigarette filters. Start a deposit-return scheme for used butts. Hold manufacturers responsible for clean-ups. Place warnings on packets about the impact of simply flicking one's used cigarettes away.
The U.S. Food and Drug Administration has ordered Sun Valley Juice Company of Ketchum, Idaho, to stop receiving, processing, preparing, packing, holding, and distributing juice until the agency determines that the company is in compliance with laws and regulations applicable to producing food that is safe.
Researchers at the University of Calgary's Hotchkiss Brain Institute and Southern Alberta Cancer Research Institute have made a discovery that could prolong the life of people living with glioblastoma – the most aggressive type of brain cancer. Samuel Weiss, PhD, Professor and Director of the HBI, and Research Assistant Professor Artee Luchman, PhD, and colleagues, published their work today in Clinical Cancer Research, which is leading researchers to start a human phase I/II clinical trial as early as Spring 2015.
Shire plc, the global specialty biopharmaceutical company, today announced that it has received approval from the US Food and Drug Administration (FDA) for INTUNIV(TM) (guanfacine) Extended Release Tablets for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17 years.
Sudden infant death syndrome (SIDS) has been a cause for concern for a while now. The New Zealand Cot Study and European data in the 1990's had found that sleeping in prone position was dangerous for infants.
› Verified 2 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 84.2 | 79.6 |
| How often patients got better at getting in and out of bed | 87.1 | 81.1 |
| How often patients got better at bathing | 84.7 | 82.3 |
| How often patients’ breathing improved | 86.6 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 95.8 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 77.4 | 75 |
| How often home health patients had to be admitted to the hospital | 13.3 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 12.9 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 96.4 | 94 |
News Archive
Ban cigarette filters. Start a deposit-return scheme for used butts. Hold manufacturers responsible for clean-ups. Place warnings on packets about the impact of simply flicking one's used cigarettes away.
The U.S. Food and Drug Administration has ordered Sun Valley Juice Company of Ketchum, Idaho, to stop receiving, processing, preparing, packing, holding, and distributing juice until the agency determines that the company is in compliance with laws and regulations applicable to producing food that is safe.
Researchers at the University of Calgary's Hotchkiss Brain Institute and Southern Alberta Cancer Research Institute have made a discovery that could prolong the life of people living with glioblastoma – the most aggressive type of brain cancer. Samuel Weiss, PhD, Professor and Director of the HBI, and Research Assistant Professor Artee Luchman, PhD, and colleagues, published their work today in Clinical Cancer Research, which is leading researchers to start a human phase I/II clinical trial as early as Spring 2015.
Shire plc, the global specialty biopharmaceutical company, today announced that it has received approval from the US Food and Drug Administration (FDA) for INTUNIV(TM) (guanfacine) Extended Release Tablets for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17 years.
Sudden infant death syndrome (SIDS) has been a cause for concern for a while now. The New Zealand Cot Study and European data in the 1990's had found that sleeping in prone position was dangerous for infants.
› Verified 2 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
Ban cigarette filters. Start a deposit-return scheme for used butts. Hold manufacturers responsible for clean-ups. Place warnings on packets about the impact of simply flicking one's used cigarettes away.
The U.S. Food and Drug Administration has ordered Sun Valley Juice Company of Ketchum, Idaho, to stop receiving, processing, preparing, packing, holding, and distributing juice until the agency determines that the company is in compliance with laws and regulations applicable to producing food that is safe.
Researchers at the University of Calgary's Hotchkiss Brain Institute and Southern Alberta Cancer Research Institute have made a discovery that could prolong the life of people living with glioblastoma – the most aggressive type of brain cancer. Samuel Weiss, PhD, Professor and Director of the HBI, and Research Assistant Professor Artee Luchman, PhD, and colleagues, published their work today in Clinical Cancer Research, which is leading researchers to start a human phase I/II clinical trial as early as Spring 2015.
Shire plc, the global specialty biopharmaceutical company, today announced that it has received approval from the US Food and Drug Administration (FDA) for INTUNIV(TM) (guanfacine) Extended Release Tablets for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17 years.
Sudden infant death syndrome (SIDS) has been a cause for concern for a while now. The New Zealand Cot Study and European data in the 1990's had found that sleeping in prone position was dangerous for infants.
› Verified 2 days ago
The patient survey data of Adventhealth Home Care Waterman is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 89 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 85 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 87 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 85 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 79 | 78 |
News Archive
Ban cigarette filters. Start a deposit-return scheme for used butts. Hold manufacturers responsible for clean-ups. Place warnings on packets about the impact of simply flicking one's used cigarettes away.
The U.S. Food and Drug Administration has ordered Sun Valley Juice Company of Ketchum, Idaho, to stop receiving, processing, preparing, packing, holding, and distributing juice until the agency determines that the company is in compliance with laws and regulations applicable to producing food that is safe.
Researchers at the University of Calgary's Hotchkiss Brain Institute and Southern Alberta Cancer Research Institute have made a discovery that could prolong the life of people living with glioblastoma – the most aggressive type of brain cancer. Samuel Weiss, PhD, Professor and Director of the HBI, and Research Assistant Professor Artee Luchman, PhD, and colleagues, published their work today in Clinical Cancer Research, which is leading researchers to start a human phase I/II clinical trial as early as Spring 2015.
Shire plc, the global specialty biopharmaceutical company, today announced that it has received approval from the US Food and Drug Administration (FDA) for INTUNIV(TM) (guanfacine) Extended Release Tablets for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17 years.
Sudden infant death syndrome (SIDS) has been a cause for concern for a while now. The New Zealand Cot Study and European data in the 1990's had found that sleeping in prone position was dangerous for infants.
› Verified 2 days ago
Adventhealth Home Care Waterman Location: 3260 Waterman Way, Tavares, Florida 32778 Ratings: Phone: (352) 253-3900 | |
Advanced Nursing Concepts Llc Location: 1599 Tropical Court, Tavares, Florida 32778 Ratings: Phone: (352) 742-9856 | |
Caringplus Homecare, Llc Location: 123 N Joanna Ave, Tavares, Florida 32778 Ratings: Phone: (352) 343-1952 |